Hu G - Search Results

1

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma.

Wang D, Wang J, Hu G, Wang W, Xiao Y, Cai H, Jiang L, Meng L, Yang Y, Zhou X, Hong Z, Yao Z, Xiao M, Chen L, Mao X, Zhu L, Wang J, Qiu L, Li C, Zhou J. Wang D, et al. Among authors: hu g. Blood. 2021 May 27;137(21):2890-2901. doi: 10.1182/blood.2020008936. Blood. 2021. PMID: 33512480 Free article. Clinical Trial.

2

Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy.

Dai Z, Hu X, Jia X, Liu J, Yang Y, Niu P, Hu G, Tan T, Zhou J. Dai Z, et al. Among authors: hu x, hu g. J Cell Physiol. 2021 Aug;236(8):5832-5847. doi: 10.1002/jcp.30267. Epub 2021 Jan 11. J Cell Physiol. 2021. PMID: 33432627

3

A novel full-human CD22-CAR T cell therapy with potent activity against CD22^low B-ALL.

Tan Y, Cai H, Li C, Deng B, Song W, Ling Z, Hu G, Yang Y, Niu P, Meng G, Cheng W, Xu J, Duan J, Wang Z, Yu X, Feng X, Zhou J, Pan J. Tan Y, et al. Among authors: hu g. Blood Cancer J. 2021 Apr 10;11(4):71. doi: 10.1038/s41408-021-00465-9. Blood Cancer J. 2021. PMID: 33839735 Free PMC article. Clinical Trial. No abstract available.

4

Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy.

Wang D, Mao X, Que Y, Xu M, Cheng Y, Huang L, Wang J, Xiao Y, Wang W, Hu G, Zhang S, Zhang T, Li C, Zhou J. Wang D, et al. Among authors: hu g. Blood Cancer J. 2021 Oct 18;11(10):168. doi: 10.1038/s41408-021-00563-8. Blood Cancer J. 2021. PMID: 34663791 Free PMC article. Clinical Trial. No abstract available.

5

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy.

Mu W, Long X, Cai H, Chen C, Hu G, Lou Y, Xing S, Wang D, Wang J, Xiao M, Wang K, Sun Z, Li C, Zhou J, Chen L. Mu W, et al. Among authors: hu g. Front Pharmacol. 2022 Feb 2;13:803693. doi: 10.3389/fphar.2022.803693. eCollection 2022. Front Pharmacol. 2022. PMID: 35185564 Free PMC article.

6

Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report.

Li D, Que Y, Ding S, Hu G, Wang W, Mao X, Wang Y, Li C, Huang L, Zhou J, Zhang W, Xiao M. Li D, et al. Among authors: hu g. J Immunother Cancer. 2022 Sep;10(9):e005403. doi: 10.1136/jitc-2022-005403. J Immunother Cancer. 2022. PMID: 36137648 Free PMC article.

7

Oncolytic herpes simplex virus delivery of dual CAR targets of CD19 and BCMA as well as immunomodulators to enhance therapeutic efficacy in solid tumors combined with CAR T cell therapy.

Liu Y, Zheng Y, Deng T, Huang Y, Liu Z, Zhan B, Zhou X, Yan R, Ren J, Xing Y, Wu G, Zheng B, Hu G, Wang W, Liu Y, Zhao J, Chen X, Zhou GG. Liu Y, et al. Among authors: hu g. Front Oncol. 2022 Oct 24;12:1037934. doi: 10.3389/fonc.2022.1037934. eCollection 2022. Front Oncol. 2022. PMID: 36353540 Free PMC article.

8

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia.

Cheng J, Ge T, Zhu X, Wang J, Zeng Y, Mu W, Cai H, Dai Z, Jin J, Yang Y, Hu G, Mao X, Zhou J, Zhu L, Huang L. Cheng J, et al. Among authors: hu g. Cancer Immunol Immunother. 2023 Jul;72(7):2331-2346. doi: 10.1007/s00262-023-03422-6. Epub 2023 Mar 17. Cancer Immunol Immunother. 2023. PMID: 36932256 Free PMC article.

9

A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma.

Wang D, Fu H, Que Y, Ruan H, Xu M, Long X, Yu Q, Li C, Li Z, Cai S, Chen W, Sun C, Hu G, Wang S, He D, Mei J, Wang W, Li C. Wang D, et al. Among authors: hu g. J Transl Med. 2023 Nov 15;21(1):812. doi: 10.1186/s12967-023-04655-w. J Transl Med. 2023. PMID: 37964302 Free PMC article.

10

The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study.

Feng Y, Cheng B, Zhan S, Liu H, Li J, Chen P, Wang Z, Huang X, Fu X, Ye W, Wang R, Wang Q, Xiang Y, Wang H, Zhu F, Zheng X, Fu W, Hu G, Chen Z, He J, Liang W. Feng Y, et al. Among authors: hu g. Eur J Nucl Med Mol Imaging. 2024 May 9. doi: 10.1007/s00259-024-06740-8. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38722381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,168 results

Search Page